MARKET

LLY

LLY

Lilly Eli & Co
NYSE
1,015.21
-9.79
-0.96%
After Hours: 1013.74 -1.47 -0.14% 19:59 02/11 EST
OPEN
1,026.50
PREV CLOSE
1,025.00
HIGH
1,030.10
LOW
1,012.62
VOLUME
2.60M
TURNOVER
--
52 WEEK HIGH
1,133.95
52 WEEK LOW
621.50
MARKET CAP
959.76B
P/E (TTM)
44.23
1D
5D
1M
3M
1Y
5Y
1D
Baron Opportunity Fund Q4 2025 Contributors And Detractors
Seeking Alpha · 6h ago
Novo Nordisk said to follow Lilly and sell obesity shot Wegovy in vial
Seeking Alpha · 7h ago
A Look At Eli Lilly’s Valuation After Recent Share Price Pullback
Simply Wall St · 12h ago
Pfizer: A Great Opportunity Post Earnings
Seeking Alpha · 13h ago
Top Analyst Reports for Eli Lilly, Marriott & Fortinet
NASDAQ · 15h ago
Many users of Novo Nordisk Wegovy pill new to GLP-1s - study
Seeking Alpha · 15h ago
'Novo to Follow Lilly and Sell Obesity Shot Wegovy in Vials' - Bloomberg
Benzinga · 15h ago
See Which Of The Latest 13F Filers Holds LLY
NASDAQ · 19h ago
More
About LLY
Eli Lilly and Company is a medicine company, which discovers, develops, manufactures, markets, and sells pharmaceutical products worldwide. Its cardiometabolic health products include Basaglar; Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, and others; Humulin, Humulin 70/30, and others; Jardiance; Mounjaro; Trulicity; Zepbound; VERVE-102; VERVE-201, and VERVE-301. Its oncology products include Cyramza, Erbitux, Tyvyt, and Verzenio. Its immunology products include Ebglyss, Olumiant, Omvoh, and Taltz. Its neuroscience products include Emgality and Kisunla. The Company is also engaged in radiopharmaceutical discovery, development, and manufacturing efforts, and clinical and pre-clinical radioligand therapies in development for the treatment of cancer. It is also developing an oral small molecule inhibitor of a4b7 integrin for inflammatory bowel disease (IBD). It is evaluating its novel gene therapy candidate, ixoberogene soroparvovec.

Webull offers Eli Lilly And Co stock information, including NYSE: LLY real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, LLY stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading LLY stock methods without spending real money on the virtual paper trading platform.